Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 2019, after the close of the U.S. financial markets. Will McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call

Full Story →

Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 2019, after the close of the U.S. financial markets. Will McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call

Full Story →

Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 2019, after the close of the U.S. financial markets. Will McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call

Full Story →

Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 2019, after the close of the U.S. financial markets. Will McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call

Full Story →